Company Profile

Verge Genomics

Verge Genomics has developed an advanced all-in-human AI-powered platform to expedite the process of discovering new drugs.

Headquarters

San Francisco, California, USA

Year Founded

2015

Top Impacted Industries

Pharmaceuticals, Biotechnology, Drug Discovery, Neuroscience, Life Sciences

About Us

Verge Genomics, now operating as Verge Labs, develops AI systems that analyze human biological and patient data for neuroscience drug development. Its CONVERGE platform identifies potential drug targets, characterizes disease biology, identifies biomarkers, and helps drug developers select patient groups for clinical trials. The technology focuses on neurological diseases and uses multimodal genomic, proteomic, and clinical data to support drug research.

Related Articles

Trending Companies

Latest Articles

futureTEKnow is focused on identifying and promoting creators, disruptors and innovators, and serving as a vital resource for those interested in the latest advancements in technology.

© 2026 All Rights Reserved.